Aperiam Bio, Inc. — Form D
Aperiam Bio, Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-27. $4.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-09-27
- Form: D
- Accession: 0001956434-23-000003
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $4.0M
- Minimum investment: $100K
- Investors: 2
- Date of first sale: 2023-09-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-493177
Issuer
- Name: Aperiam Bio, Inc.
- CIK: 0001911739
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 2205 NORTH LAMAR BLVD. UNIT 511, AUSTIN, TX, 78705
- Phone: 512-318-5584
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Austin Cole | Director | Austin, TX |
| Austin Cole | Executive Officer | Austin, TX |
Other filings by this issuer (1)
More